Speaking to a congressional panel on Thursday, the head of the Food and Drug Administration (FDA) acknowledged that his agency has taken little regulatory action on CBD products in recent years despite the federal legalization of hemp and its derivatives. “It looks pretty much the same in terms of where we are now,” FDA Commissioner … Continue reading FDA Head Admits Agency Has Been Slow To Regulate CBD, But Suggests Congress Needs To Do More